Literature DB >> 292453

Influence of the hypoxic cell sensitizer misonidazole on the proliferation of well-oxygenated cells in vitro during prolonged exposure.

B F Deys, J Stap.   

Abstract

Analysis of time-lapse cinematographic film permitted the construction of pedigrees from 88 well oxygenated cells of a mouse osteosarcoma (MOS). These cells have been chronically treated with various concentrations of the hypoxic cell sensitizer misonidazole (MIS) over periods of up to 96 h. At concentrations of 0.5 and 7 mM there is a 2--3 h increase in cell-cycle time. Concentrations of 2 mM show an intermitotic time delay of 7.6--10.3 h. At 4 mM cells divided only once. With increasing drug concentration there was an increase in the number of abnormal mitoses. These results were compared with cloning efficiency (PE) experiments. PE at 0.5 mM is 80%, at 1 mM 40 and at 2 mM is reduced to 4%. Cells treated with 2mM MIS over a period of 28.6 h resume their normal cycle when the drug is washed from the culture. This may indicate that DNA is not a major target for MIS. It is concluded that this hypoxic cell sensitizer is also toxic for MOS cells in well oxygenated conditions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 292453      PMCID: PMC2010114          DOI: 10.1038/bjc.1979.258

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Hyperthermic potentiation of cytotoxicity of Ro-07-0582 in multicell spheroids.

Authors:  R Sridhar; R Sutherland
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 May-Jun       Impact factor: 7.038

2.  Cytotoxicity of misonidazole and DNA damage in hypoxic mammalian cells.

Authors:  B Palcic; L D Skarsgard
Journal:  Br J Cancer Suppl       Date:  1978-06

Review 3.  Chemical radiosensitization of hypoxic cells.

Authors:  G E Adams
Journal:  Br Med Bull       Date:  1973-01       Impact factor: 4.291

4.  In vitro studies on the radioresistance of oxic and hypoxic cells in the presence of both radioprotective and radiosensitizing drugs.

Authors:  J M Yuhas; A P Li
Journal:  Radiat Res       Date:  1978-09       Impact factor: 2.841

5.  Studies on the toxicity and radiosensitizing ability of misonidazole under conditions of prolonged incubation.

Authors:  T W Wong; G F Whitmore; S Gulyas
Journal:  Radiat Res       Date:  1978-09       Impact factor: 2.841

6.  Cytotoxic effects of the hypoxic cell radiosensitizer Ro 7-0582 to tumor cells in vivo.

Authors:  J M Brown
Journal:  Radiat Res       Date:  1977-12       Impact factor: 2.841

7.  Toxic and radiosensitizing effect of the 2-nitroimidazole misonidazole (Ro-07-0582) on murine CFU in vivo.

Authors:  E O Pettersen
Journal:  Br J Cancer Suppl       Date:  1978-06

8.  Effect of hyperthermia on differential cytotoxicity of a hypoxic cell radiosensitizer, Ro-07-0582, on mammalian cells in vitro.

Authors:  I J Stratford; G E Adams
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

9.  Cytotoxicity of Ro-07-0582; enhancement by hyperthermia and protection by cysteamine.

Authors:  E J Hall; M Astor; C Geard; J Biaglow
Journal:  Br J Cancer       Date:  1977-06       Impact factor: 7.640

10.  Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses.

Authors:  S Dische; M I Saunders; M E Lee; G E Adams; I R Flockhart
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.